Global Genomic Sequencing Technologies Market US$ 7.2 Billion by 2021

The global genomic sequencing technologies market expected to reach US$ 7.2 billion by 2021, growing at CAGR 14% over the forecast period 2017-2021, mainly due to high-throughput - next generation sequencing technologies, and advances in personalized medicine.

Genomic sequencing technologies have revolutionized biology, with impacts ranging from the sequencing of several model genomes to the birth of a new era for pharmacogenomics. In recent years, there has been an increasing fragmentation of the genomic sequencing (GS) technologies market as several competing manufacturers launched NGS platforms. The high-throughput - next generation sequencing (HT-NGS) technologies are revolutionizing the human and animal genome researches by analysis of chromatin immunoprecipitation coupled to DNA microarray (ChIP-chip) or sequencing (ChIP-seq), RNA sequencing (RNA-seq), whole genome genotyping, genome wide structural variation, de novo assembling and re-assembling of genome, mutation detection and carrier screening, detection of inherited disorders and complex human diseases.

Browse Genomic Sequencing Technologies Market by Product Type (Sequencing Instruments, Reagents & Consumables, Sequencing Services), Application (Commercial, Healthcare, Research) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/genomic-sequencing-technologies-market/

The global genomic sequencing technologies market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global genomic sequencing technologies market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global genomic sequencing technologies market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global genomic sequencing technologies market and profiled in this report include Agilent Technologies, Genia, Illumina (BlueGnome/ Verinata), International Business Machines Corp., Knome, Inc., Oxford Nanopore Technologies, Pacific Biosciences, Raindance Technologies, Inc., Roche, Thermo Fisher Scientific (Life Technologies/Navigenics), and Torrent Systems.

1. Product Type
1.1. Sequencing Instruments, reagents and consumables
1.2. Sequencing Services

2. Application
2.1. Commercial
2.2. Healthcare
2.3. Research

3. Geography
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Agilent Technologies
4.2. Genia
4.3. Illumina (BlueGnome/ Verinata)
4.4. International Business Machines Corp.
4.5. Knome, Inc.
4.6. Oxford Nanopore Technologies
4.7. Pacific Biosciences
4.8. Raindance Technologies, Inc.
4.9. Roche
4.10. Thermo Fisher Scientific (Life Technologies/Navigenics)
4.11. Torrent Systems

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/genomic-sequencing-technologies-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.